part of a law pharmaceutical companies have pledged to revisit with the Trump administration. Healthcare & Pharmaceuticalscategory US turkey producers should ramp up bird flu testing, USDA says ...

Although Recursion Pharmaceuticals offers compelling possibilities, I believe that without better visibility into its product approval pathway, it's just too early to buy this stock with conviction.

Senores Pharmaceuticals IPO Allotment Today: At the upper price band, the company is valued at a P/E of 55x with a market cap of Rs 1800.6 crore (Image: Freepik) Senores Pharmaceuticals IPO closes ...

The hefty tariffs President-elect Trump has pledged to levy on U.S. imports could impact the price and availability of pharmaceutical drugs. Trump has floated 25 percent tariffs on imports from ...

President-elect Trump’s plan to enact heavy tariffs on certain imports could affect the prices and availability of pharmaceutical drugs in the U.S. Trump has floated 25 percent tariffs on ...

A Reuters analysis of prices for new drugs found that pharmaceutical companies launched new U.S. drugs in 2023 at prices 35% higher than in 2022. The over 250 drug hikes represent an increase from ...

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

After hours: January 8 at 4:44:37 PM EST Loading Chart for ANIP ...

After hours: January 17 at 5:31:24 PM EST Loading Chart for SNDX ...

Shares of Neimeth International Pharmaceuticals Plc have risen by over 32% in the third week of January 2025, pushing its month-to-date performance to over 50%. This increase follows the company’s ...

Companies that have grown profits and net profit margins over the past 12 months ...

Jan. 15, 2025 — Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug ...